View More
In this concise video, gain expert insights on using shared decision-making with patients with IBD who are initiating biologic therapy and learn to effectively discuss data on malignancy risk associated with IBD therapies.
Millie D. Long, MD, MPH, FACG, AGAF
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Released: June 23, 2021
Expired:
June 22, 2022
Review best practices of shared-decision making and discussing risk of cancer when discussing initiation of biologic therapy with patients who have IBD.
Millie D. Long, MD, MPH, FACG, AGAF
Released: June 24, 2021
“Activated” patients with IBD understand their care and have the skills and confidence to manage its intricacies. They also have better outcomes.
Millie D. Long, MD, MPH, FACG, AGAF
Released: July 13, 2021
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.